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Abstract
Background: Intestinal stem cell transplantation has been shown to promote mucosal healing and to engender
fully functional epithelium in experimental colitis. Hence, stem cell therapies may provide an innovative approach
to accomplish mucosal healing in patients with debilitating conditions such as inflammatory bowel disease. However,
an approach to label and trace transplanted cells, in order to assess engraftment efficiency and to monitor wound
healing, is a key hurdle to overcome prior to initiating human studies. Genetic engineering is commonly employed in
animal studies, but may be problematic in humans due to potential off-target and long-term adverse effects.
Methods: We investigated the applicability of a panel of fluorescent dyes and nanoparticles to label intestinal organoids
for visualization using the clinically approved imaging modality, confocal laser endomicroscopy (CLE). Staining
homogeneity, durability, cell viability, differentiation capacity, and organoid forming efficiency were evaluated,
together with visualization of labeled organoids in vitro and ex vivo using CLE.
Results: 5-Chloromethylfluorescein diacetate (CMFDA) proved to be suitable as it efficiently stained all
organoids without transfer to unstained organoids in co-cultures. No noticeable adverse effects on viability,
organoid growth, or stem cell differentiation capacity were observed, although single-cell reseeding revealed
a dose-dependent reduction in organoid forming efficiency. Labeled organoids were easily identified in vitro
using CLE for a duration of at least 3 days and could additionally be detected ex vivo following
transplantation into murine experimental colitis.
Conclusions: It is highly feasible to use fluorescent dye-based labeling in combination with CLE to trace
intestinal organoids following transplantation to confirm implantation at the intestinal target site.
Keywords: Cell labeling, Confocal laser endomicroscopy, Colitis, Fluorescent dyes, Intestinal organoids,
Intestinal stem cells, Nanoparticles, Transplantation
Background
Intestinal stem cells situated at the base of crypts of Lie-
berkühn generate progeny that replace resident cells,
which are shed from the tip of villi as part of the homeo-
static process. These stem cells can in vitro be propagated
as organoids [1], and orthotopic transplantation in murine
models of mucosal injury has revealed that intestinal orga-
noids are able to spontaneously attach and integrate into
the damaged epithelium [2–5], thereby accelerating the
healing process with subsequent improvement in weight
gain [3]. This suggests that transplantation of intestinal
stem cell might be applicable in humans to actively pro-
mote mucosal healing [6] and could potentially be used to
treat a wide range of gastrointestinal disorders, including
inflammatory bowel disease, in which mucosal healing is a
pivotal treatment goal [7, 8] and the most important
predictor of clinical remission [9–11]. A method to trace
transplanted cells in vivo is, however, essential to assess
engraftment efficiency and to monitor wound healing,
especially in the preclinical phase.
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Confocal laser endomicroscopy (CLE) is an established
and clinically approved endoscopic modality permitting
high-resolution and real-time imaging of fluorophores in
distinct spatial planes [12, 13]. Although fluorescence has
limited penetration depth, CLE is able to get very close to
the mucosa, thereby mitigating such limitations. At the
same time, CLE allows for endoscopic evaluation of the
intestinal wound surface [12, 13], which in turn is not pos-
sible using other labeling methods such as single-photon
emission computed tomography, positron emission
tomography, or magnetic resonance imaging (MRI).
In previous murine studies of intestinal transplantation
[2–5], cells were genetically engineered to express green
fluorescent protein. Although this constitutes a long-lasting
labeling technique, such a strategy may cause off-target
genetic alterations with unknown long-term adverse effects
in humans [14]. Therefore, we investigated the applicability
of a panel of readily available fluorescent dyes and nanopar-
ticles using intestinal organoids as well as orthotopic
transplantation in an experimental colitis model. The dyes
included fluorescein, 5-chloromethylfluorescein diacetate
(CMFDA), a carbocyanine-based dye, along with an inert
membrane permeable dye. Additionally, two different types
of nanoparticles were studied (quantum dots and dye-
loaded poly lactic-co-glycolic acid (PLGA) nanoparticles),
which both have been used to track and manipulate other
cell types [15–17]. The dyes and nanoparticles were chosen
based on an expected retention time of at least 24 h, and
selection was limited to dyes and particles emitting in the
green spectrum, because clinically approved CLE endo-
scopes are equipped solely with a 488-nm excitation laser.
The different labeling techniques were evaluated in
terms of homogeneity, transfer to adjacent unlabeled cells,
and effects on cell viability and function, as well as fluores-
cent signal intensity and durability. The aim of the study
was to investigate the feasibility of fluorescent-based lon-
gitudinal tracing of intestinal epithelial cells using CLE.
Methods
Isolation of colonic crypts and establishment of organoid
cultures
Human colonic biopsies were harvested from healthy con-
trol subjects and from patients with quiescent ulcerative
colitis (endoscopic Mayo subscore 0), as described in Li et
al. [18]. In summary, samples were washed in cold Gib-
coTM Dulbecco’s phosphate-buffered saline (DPBS; Thermo
Fisher Scientific, Waltham, MA, USA), and cell dissociation
was promoted using ethylenediaminetetraacetic acid
(EDTA (8mM), Thermo Fisher Scientific) on a rocking
platform at 5 °C for 1 h. Crypts were released through
forceful shaking and subsequently homogenized in diluted
growth factor reduced Matrigel® Matrix (Corning Inc.,
Corning, NY, USA), and cultured in standard culture
medium [18, 19]. Organoids were initially cultured for two
passages, before experimental setups were initiated.
Murine colonic organoids were established from ROSA
mT/mG mice (stock.nr. 007576, Jackson Laboratory, Bar
Harbor, ME, USA) essentially as described above using
EDTA (10mM) supplemented with dithiothreitol (80 μg/
ml) (Bio-Rad Laboratories, Hercules, CA, USA) to release
the crypts from the tissue fragments. The murine organoids
were cultured in basal medium supplemented with recom-
binant R-spondin 1 (500 ng/ml) (R&D systems, MN, USA),
Gibco™ recombinant murine EGF (50 ng/ml) (Thermo
Fisher Scientific), recombinant murine Noggin (100 ng/ml)
(Peprotech, Rocky Hill, NJ, USA), Gibco™ B-27 without
vitamin A (Thermo Fisher Scientific), Gibco™ N-2 supple-
ment, Nicotinamide (10mM) (Sigma-Aldrich, St. Louis,
MO, USA), CHIR99021 (Calbiochem, San Diego, CA,
USA), PGE2 (2.5 μM) (Sigma-Aldrich), and valproic acid (1
mM) (Sigma-Aldrich).
Cell staining protocols
Organoids were stained in accordance with instructions
provided by the manufacturers, as well as previously pub-
lished protocols. All staining experiments were performed
in triplicates, and at least three separate experiments were
performed if not otherwise specified. In cases where
successful staining were obtained, each culture well was
imaged at five representative locations to assess staining
efficiency.
Fluorescein
Organoids were suspended and incubated at 37 °C in
fluorescein-laden culture medium for up to 6 h (fluores-
cein sodium salt (40 μM) [20] (Sigma-Aldrich). Orga-
noids were subsequently washed three times with basal
medium before performing fluorescence imaging.
Membrane permeable and inert dye
The culture medium was supplemented with an inert and
membrane permeable green fluorescent dye (40–400 μg/
ml) (Phosphorex, Hopkington, MA, USA) for up to 24 h,
or cells were stained in suspension for up to 6 h. Three
washing procedures were performed before fluorescence
imaging.
CMFDA
Organoids were suspended in a basal medium solution
containing 5, 15 or 25 μM of green CMFDA (CellTracker™,
Thermo Fisher Scientific) and incubated at 37 °C for 45
min. Three consecutive washes were then performed
before imaging.
Carbocyanine-based cytoplasmic membrane dye
Organoids were stained in suspension at 37 °C in 1ml of
basal medium supplemented with 5 μl of CellBrite™ green
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cytoplasmic membrane dye (Biotium, Fremont, CA, USA)
for up to 40min. Cells were repeatedly washed with basal
medium before fluorescence observation.
Quantum dots
A 2–15 nM labeling solution of Qtracker® 525 cell label-
ing kit (Thermo Fisher Scientific) was prepared by
pre-mixing its two components (nanocrystals and a cus-
tom carrier). The solution was incubated at 37 °C for 5
min, after which 200 μl of culture medium containing
suspended organoids or single cells was added to the la-
beling solution. The mixture was incubated at 37 °C for
up to 1 h. Cells were afterwards washed twice and im-
aged. Staining was similarly pursued using the same
staining protocol after single-cell dissociation.
Fluorescent PLGA nanoparticles
Green fluorescent PLGA nanoparticles loaded with a
BOPIDY-FL dye (Thermo Fisher Scientific) and with an
average diameter of 150.6 nm (SD = 5.3 nm) were produced
by single emulsion solvent evaporation techniques [21]
with a lactide to glycolide ratio of 1:1 and a MW of 30.000
(Lactel Absorbable Polymers, Birmingham, AL, USA).
The surface charge of the particles was modified using
poly-L-lysine (PLL) solution. In brief, 5 mg of lyophilized
particles was resuspended in PLL solution (0.01%, w/v)
(Sigma-Aldrich) and the suspension was shaken at 37 °C
for approximately 2 h [21].
The ζ-potential of the PLGA particles were measured in
distilled water using a Nano-ZS90 Zetasizer (Malvern Instru-
ments Ltd., Malvern, UK). The ζ-potential of uncoated and
PLL-coated PLGA nanoparticles was − 21.4mV (SD= 4.31)
and + 13.2mV (SD= 3.58), respectively. Uncoated or PLL-
coated particles were reconstituted in basal medium and
were briefly probe-sonicated with a Branson Digital Sonifier
450 (Branson Ultrasonics, Dietzenbach, Germany), and the
PLGA-basal medium solution was subsequently used to pre-
pare a particle-laden culture medium with a PLGA concen-
tration of 0.1mg/ml [21]. The culture medium was added to
each culture well for a duration of 24 h. Alternatively, parti-
cles were mixed into the diluted Matrigel® solution to
minimize the diffusion distance [22]. Labeling of organoids
as well as single cells were similarly attempted using a
particle-laden suspension for 4–6 h at 37 °C.
Evaluation of intercellular transfer
The utility of the staining techniques by which organoids
were effectively labeled were further assessed in terms of
intercellular transfer. Organoids were stained with green
CMFDA (15 μM), carbocyanine-based cytoplasmic mem-
brane dye (5 μl/ml), or the green membrane permeable
inert dye (40 μg/ml). After completion of three consecu-
tive washing steps, stained organoids were carefully mixed
with unstained organoids and were seeded in three culture
wells per condition. Standard culture medium was added,
after which wells at culture initiation were imaged using a
fluorescent microscope as well as after 24 h, to evaluate
whether any consequential transfer occurred to adjacent
unstained organoids.
Flow cytometry—fluorescence intensity and durability
The fluorescence signal intensity and durability were only
quantified for CMFDA, as it proved the most applicable of
the labeling techniques studied. Organoids were stained
with green CMFDA (5, 15, or 25 μM) and subsequently
washed three times, after which the fluorescence inten-
sities were determined by flow cytometry. Additionally,
organoids stained with CMFDA (15 μM) were reseeded in
Matrigel® and cultured for up to 7 days. At each time point
(day 0, 1, 2, 3, 4, and 7), organoids were harvested for ana-
lysis to assess the staining durability. This was performed
once with three biologic replicates.
Organoids were harvested using Corning® Cell Recovery
Solution, after which they were enzymatically dissociated
into single cells by incubation in TrypLE Express 1x
(Thermo Fisher Scientific) for 20min at 37 °C. Cells were
subsequently stained with of eFlour™780 viability dye (1 μl)
(Thermo Fisher Scientific) per 106 cells/ml for 15min, after
which cells were washed in DPBS containing BSA (0.1%).
All samples were run on a BD FACS Canto™ II system
(Becton Dickinson, Franklin Lakes, NJ, USA) and ana-
lyzed using BD FACSDiva software 8.0.1. PMT voltages
were set manually by running samples of relevant cells.
Compensation settings for eFlour™780 (APC-Cy7chan-
nel) and green CMFDA (FITC channel) were attained
using the software’s automated compensation controls.
The epithelial cell population was identified based on
FSC-A and SSC-A, whereas FSC-H and FSC-A were
correlated to identify singlets, after which eFlour™780/
APC-Cy7-negative cells were isolated for ensuing ana-
lysis. Approximately 10,000 colonic epithelial cells were
run per sample. The signal in unstained controls was
used to quantify autofluorescence at baseline. Gating
strategies are displayed in Additional file 2: Figure S1.
Organoid forming efficiency following single cell seeding
Organoids were cultured in standard cultured medium for
7 days and subsequently enzymatically passaged into single
cells using TrypLE express, as described above for flow cy-
tometry. The single cells were subsequently stained with
green CMFDA (5, 15, or 25 μM), after which they were
washed and homogenized in diluted Matrigel®, supple-
mented with Jagged-1 (1 μM) (AnaSpec, Fremont, CA,
USA) [23] and seeded in triplicates. Cells were cultured in
standard medium (without supplementation of ROCK in-
hibitor) for a duration of 10 days. At day 10, the number of
organoids was determined manually using an inverted
digital light microscope. Six experiments were performed
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in total and included unstained DMSO (dimethylsulfox-
id)-control samples as well as cells that briefly were treated
with Triton™ X-100 (5%) (Sigma-Aldrich).
PrestoBlue™ cell viability assay
Cell viability following labeling was assessed using the Pre-
stoBlue™ cell viability assay (Thermo Fisher Scientific).
Organoids were mechanically dissociated by brief pipetting
and divided into five comparable samples (5, 15, or 25 μM
of CMFDA, as well as a positive and negative control) and
labeled in accordance with previously described staining
protocol. Cells were seeded in Matrigel® and cultured in
standard culture medium for 24 h and 48 h. At each time
point, the culture medium was replaced fresh medium
supplemented with PrestoBlue™ cell viability reagent (10%)
(Thermo Fisher Scientific). Organoids were incubated for
3–4 h after which 150 μl of the medium from each well
was transferred to a 96-well plate (TPP, Trasadingen,
Switzerland). Fluorescence was measured using a Synergy
HT plate reader (BioTek Instruments, Winooski, VT,
USA), excitation 530/25 emission 590/35. The positive
control was very briefly treated with Triton™ X-100 (5%).
In total, six experiments were performed in triplicates for
each time point, and all viability data were compared to
unstained DMSO-control samples.
Hematoxylin and eosin staining and gene expression
analysis of differentiation markers
Effects of staining with CMFDA on the stem cell differenti-
ation capacity and the expression of marker genes were
studied by comparing unstained and stained cells, cultured
for 3 days in differentiation medium without Wnt3a,
R-spondin 1, SB202190, and nicotinamide [19]. Gene
expression levels in organoids cultured in standard prolifer-
ation medium were used to verify induction of differenti-
ation. Organoids were harvested using Corning® Cell
Recovery Solution and lysed in PR1 buffer (Macherey-Na-
gel, Düren, Germany). RNA extraction was performed
using a NucleoSpin®RNA purification kit (Macherey-Nagel),
and reverse transcription was ensured using a Mastercycler®
(Eppendorf, Hamburg, Germany). All samples were run in
three technical replicates on a LightCycler® 480 (Roche, Ba-
sel, Switzerland) system, and six individual experiments
were performed in total. The following lineage-specific dif-
ferentiation markers were used: leucine-rich
repeat-containing G-protein coupled receptor 5 (LGR5; in-
testinal stem cells), mucin 2 (MUC2; goblet cells), carbonic
anhydrase II (CAII, mature enterocytes), and chromogranin
A (CHGA; enteroendocrine cells). TATA-Box Binding
Protein (TBP) was used as internal reference genes to
normalize quantitative gene expression data. All primer
sequences are listed in Additional file 1: Table S1.
Additionally, before and after differentiation, CMFDA-
stained organoids were centrifuged and embedded into
an artificial clot generated by adding a few drops of hu-
man plasma (produced in house) and bovine thrombin
(CAS.9002-04-4, Merck, Darmstadt, Germany). Cells were
then fixed with paraformaldehyde (4%) (Sigma-Aldrich)
and embedded into paraffin. Slides were stained with
hematoxylin-eosin before microscopic evaluation of cell
distribution, nuclear features, and organoid morphology.
Furthermore, organoids were stained with the cytokeratin
20 (CK20; FLEX monoclonal mouse anti-human cytokera-
tin 20, clone K 20.8, ready-to-use, cat.GA777, DAKO, Agi-
lent Technologies), a general marker for colonic epithelial
differentiation.
Visualization of labeled and unlabeled cells in vitro using
CLE
At days 0 and 3, stained organoids were visualized using an
endoscope-based Pentax ISC-OU1000 system with a Pen-
tax EC-3870 CIFK confocal laser endomicroscope (Pentax,
Tokyo, Japan). This system is approved for clinical use and
has a miniature confocal microscope integrated into the tip
of a conventional endoscope. The tip of the endoscope was
placed in the culture well within the Matrigel® dome, and
consecutive spatial planes were imaged. Unstained
DMSO-samples were used to validate that no epithelial au-
tofluorescence could be detected. Organoids derived from
mT/mg mice expressing the tdTomato fluorescent protein
were also imaged in vitro with CLE.
Transplantation of intestinal epithelial cells into a DSS-
model and ensuing imaging
Transplantation was performed in accordance with a previ-
ously published protocol [24], although with minor modifi-
cations. RAG2−/− mice (cat. B6.129S6-Rag2tm1FwaN1,
Taconic Biosciences, Rensselaer, NY, USA) were treated
with dextran sodium sulfate (3.2%) (DSS; 36000–50,000
MW, colitis grade, MP Biomedicals, Santa Ana, CA, USA)
in the drinking water for 5 days, and transplantations were
performed 9 days after initiation of the DSS administration.
Colonic organoids derived from mT/mG mice were
released from Matrigel® and mechanically dissociated into
sheets of epithelial cells before incubation with CMFDA
(15 μM) at 37 °C for 45min followed by three washes.
RAG2−/− mice were anesthetized by inhalation of isoflur-
ane (2.5–3%) (cat. 055226, ScanVet Animal Health,
Fredensborg, Denmark), and a suspension of organoid frag-
ments from approximately 1000 colonic organoids resus-
pended in DPBS (300 μl) with Matrigel® (5%) was infused
into the colonic lumen using a syringe and thin flexible
catheter. After infusion, the anal verge was glued for 3 h,
and animals were sacrificed 24 h after transplantation. The
timeline is depicted in Fig. 5b. Colons were harvested, and
tdTomato- and CMFDA-positive regions were identified
and imaged using a fluorescence dissecting microscope and
with CLE.
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Statistical analysis
Statistical analyzes were performed using GraphPad
Prism 8.0.0. Wilcoxon matched-pairs signed rank test
was used to analyze cell viability, organoid forming effi-
ciency, and gene expression data. Decline in fluorescence
signal intensity determined by flow cytometry was ana-
lyzed by performing log2 transformation and subsequent
linear regression. Results were considered statistically
significant at p < 0.05.
Results
Staining outcome and homogeneity
Fluorescein failed to stain any of the cells and merely accu-
mulated in the organoid lumen (Fig. 1a), whereas CMFDA,
the membrane permeable inert dye, as well as the
carbocyanine-based cytoplasmic membrane dye, were easily
internalized in the cells and effectively stained the orga-
noids (Fig. 1b–d). Both the inert dye and CMFDA stained
the organoids uniformly and appeared to stain all cells
(Fig. 1b, c). In contrast, the carbocyanine-based cytoplasmic
membrane dye (Fig. 1d) only stained a subset of the orga-
noids homogeneously (median = 31%, ICR = 5–65%),
whereas a comparable fraction of organoids were either
heterogeneously stained (median = 44%, ICR = 4–52%) with
only a subset of cells labeled or not stained at all (median =
25%, ICR = 4–65%).
Attempted staining of organoids or single cells with
PLGA nanoparticles in suspension resulted in some parti-
cles (uncoated and coated alike) becoming membrane-asso-
ciated around the organoid periphery, but without obvious
signs of actual internalization of the nanoparticles (Fig. 1e).
Similarly, no staining was achieved when the PLGA nano-
particles (coated or uncoated) were added to the Matrigel®
solution before polymerization or when added to the cul-
ture medium, as the particles aggregated around the orga-
noids or were trapped in the periphery of the Matrigel®
dome.
Labeling of whole organoids or single cells using quantum
dots similarly failed, as particles merely gathered near the
cells or organoids and were not internalized (Fig. 1f).
Intercellular transfer of the dyes
No transfer of dye was observed when organoids stained
with CMFDA or carbocyanine-based cytoplasmic mem-
brane dye were co-cultured with unstained organoids for
24 h (Fig. 2a, b). The median fraction of unstained orga-
noids at culture initiation was 30% (ICR = 22–44%) and
50% (ICR = 50–66%) for CMFDA and the carbocyanine-
based cytoplasmic membrane dye, respectively. After 24 h,
the fractions were maintained at comparable levels
(CMFDA median: 40%, ICR = 33–50% and carbocyanine-
based dye 50%, ICR = 33–66%). However, rapid transfer of
the membrane permeable inert dye from stained to
unstained organoids was observed, making these two
populations indistinguishable after approximately 1 h
(Fig. 2c), with no unstained organoids remaining.
Fluorescence signal intensity and durability
Since CMFDA was the only dye that efficiently stained
the organoids without transferring to neighbouring
unstained cells, further studies were only carried out for
this fluorophore. The CMFDA-derived fluorescent signal
intensity increased exponentially with increasing
concentration (5–25 μM, Fig. 3a), and 99% of cells were
CMFDA-positive, as determined by flow cytometry.
The fluorescence signal intensity of intestinal epithelial
cells stained with of CMFDA (15 μM) was reduced by t½
of 0.99 days (r2 = 0.96, Fig. 3b). The signal intensity
approached levels in unstained cells approximately 4–7
days after staining.
Cell viability and organoid forming capacity
The PrestoBlue™ viability assay did not reveal any statisti-
cally significant reduction in cell viability 24 h or 48 h after
staining of organoid fragments with 5–25 μM of CMFDA
(Fig. 3c, d). The organoid forming capacity following single-
cell seeding was notably affected with increasing concentra-
tion of CMFDA (Fig. 3e). No atypical growth behavior of
CMFDA-labeled organoids (cultured from fragments) was
observed, and organoids visibly continued to grow (Fig. 3f).
Some events of organoids dissociation were observed after
staining but no clear concentration-dependent trend was
observed, and it was not sufficiently prevalent to be
detected by the viability assay.
Cell differentiation and gene expression analysis
Upon induction of differentiation, a significant increase in
the expression of CA II and MUC2 was observed, with no
difference between unstained and CMFDA-stained cells
after differentiation (Fig. 4a, b). In both CMFDA-stained
cells and DMSO-controls, a statistically significant
decrease was detected in the LGR5 expression (p < 0.05)
upon induction of differentiation (Fig. 4c). The median ex-
pression level of LGR5 after differentiation was 0.8%, ICR =
0.5–1.2% (CMFDA) and 1.6%, ICR = 0.7–4.9% (DMSO-con-
trols) of levels in unstained cells before differentiation, and
the difference proved to be statistically significant (p < 0.05).
The expression of CHGA proved to be undetectable in
several samples (both stained and unstained cells,
Fig. 4d), but with a clear trend towards increased expres-
sion levels following induction of differentiation.
H&E staining and subsequent microscopic evaluation of
CMFDA-labeled organoids along with unstained DMSO-
control organoids revealed increasingly differentiated cell
morphology with simple columnar epithelium in both
conditions. Absorptive colonocytes as well as goblet cells
with mucus filled vacuoles could easily be identified, with a
rich luminal accumulation of mucus. Nuclei were basally
Bergenheim et al. Stem Cell Research & Therapy          (2019) 10:148 Page 5 of 12
located and primarily spherical in shape (Fig. 4e). A very
strong positive reacted for CK20 was detected after differ-
entiation in both conditions (Fig. 4e).
Imaging of labeled cells in vitro with CLE
Intestinal organoids could effectively be identified with CLE
for at least 3 days following staining with CMFDA (Fig. 5a).
In addition to organoid identification, rudimentary morph-
ology and 3D structure, as well as occasional budding,
could be distinguished. No autofluorescence from un-
stained organoids was detected.
Ex vivo imaging of CMFDA-labeled cells
To assess whether labeled cells could be identified ex vivo,
transplantation of CMFDA-labeled cells was performed
using a murine DSS-model [3, 5]. Twenty-four hours after
transplantation, fluorescent regions of the colon (three
separate regions in two different recipient mice) were
Fig. 1 Staining of human colonic organoids. Fluorescent imaging of intestinal organoids stained with fluorescent dyes or nanoparticles, along with
assessments of staining quality (homogeneous, heterogeneous or unstained). Standard fluorescent microscopy of organoids stained with a fluorescein,
depicting accumulation in the organoid lumen, b an inert membrane permeable dye, c CMFDA or d a carbocyanine-based cytoplasmic membrane
dye. e Confocal fluorescent imaging showing membrane-associated PLGA nanoparticles that have not been internalized into the cells. Nuclei are
stained with Hoechst 33342. f Standard fluorescent imaging of intestinal organoids after attempted staining with quantum dots, depicting particle
aggregation in proximity of the organoid. White scale bar, 100 μm
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identified ex vivo as both CMFDA- and TdTomato-positive
using a fluorescence dissecting microscope (Fig. 5c). The
corresponding fluorescent signal could similarly be
detected with CLE by placing the tip in contact with the
mucosa (Fig. 5d). No fluorescent signal was detected from
the surrounding regions and imaging of mT/mG organoids
confirmed that the tdTomato signal was not readily
detected by the CLE, unlike the CMFDA signal (Add-
itional file 3: Figure S2).
Discussion
For efficient dye-based fluorescent tracing in vivo, the dye
must efficiently and homogenously stain the cells without
affecting their viability or function, while also transferring
to daughter cells. Additionally, it is important that the stain
does not transfer to adjacent resident cells, as this would
render it useless for tracing purposes. Hence, fluorescein,
the freely membrane permeable dye and the carbocyanine-
based dye proved to be ineligible, whereas CMFDA ap-
peared to display the necessary qualities for this type of tra-
cing application. Once it passes through the plasma
membrane, it becomes membrane impermeable through a
supposed glutathione-mediated process, and a subsequent
reaction with thiol groups of intracellular proteins. CMFDA
staining did not appear to significantly affect organoid func-
tions or viability, at least not when staining organoid
fragments. In fact, organoids derived from fragments con-
tinued to grow and maintained normal viability following
CMFDA staining, as indicated by the PrestoBlue™ viability
data. However, a concentration-dependent effect was ob-
served on the organoid forming efficiency of single cells,
and it has been reported in epithelial cancer cell lines that
CMFDA can affect the mechanical properties of single
cells [25]. The effect was notably less pronounced
when using CMFDA at a concentration of 15 μM, and
this concentration remained applicable for tracing
purposes. Intestinal stem cell transplantation is per-
formed with organoid fragments instead of single cells
and we therefore do not expect CMFDA to affect the
regenerative capacity of organoid fragments. Interest-
ingly, in a recent human skin wound healing assay,
wound healing was maintained despite consecutive
staining with CMFDA [26].
CMFDA staining did not appear to restrain cell dif-
ferentiation into absorptive or secretory lineage, and
cells clearly attained a more differentiated phenotype,
comparable to unstained cells, after induction of dif-
ferentiation. Nonetheless, induction of differentiation
in vitro by removal of critical niche factors occurs at
the expense of organoid maintenance, which leaves a
narrow window to study cell differentiation [27]. To
quantify the stem cell progeny and to thoroughly as-
sess any effects of CMFDA will likely require trans-
plantation, as additional cell differentiation can be
achieved in vivo [2, 3, 28, 29]. The difference in
LGR5 expression in vitro following differentiation was
relatively modest and did not seem to affect organoid
growth but could theoretically be at least partially re-
sponsible for the effect on single-cell organoid forming
capacity. The expression of CHGA could be detected
only in a few samples (both stained and unstained).
This observation is not surprising, as enteroendocrine
cells only comprise < 1% of the total number of cells of
the intestinal epithelium.
Fig. 2 Intercellular dye transfer. Fluorescent and brightfield imaging of co-cultures of unstained and stained colonic organoids, along with
quantitative assessment of dye transfer. Organoids were stained with a CMFDA, b carbocyanine-based cytoplasmic membrane dye or with c an
inert membrane permeable dye. Images were taken at initiation of the co-cultures as well as 24 h later. White scale bar, 50 μm
Bergenheim et al. Stem Cell Research & Therapy          (2019) 10:148 Page 7 of 12
We observed a fluorescence signal retention of roughly
4–7 days in CMFDA-stained cells, with a decline in
fluorescence over time most likely by means of dilution
as cells divided. Nonetheless, CMFDA-stained cells
could efficiently be identified using CLE in vitro for at
least 3 days. Albeit the CMFDA-signal intensity depends
on a combination of factors (e.g., the proliferation rate,
the intracellular amount of CMFDA, as well as the num-
ber of cells), CMFDA-based tracing may be applicable
for even longer than 3 days in vivo, as human colonic
stem cells have been found to be slow cycling [4].
In an attempt to increase the longitudinal duration of
fluorescence-based tracing, we included the dye-loaded
PLGA nanoparticles and quantum dots in our investiga-
tion. Cell uptake of quantum dots is dependent on conjuga-
tion with targeting ligands such as peptides, arginine-
glycine-aspartate (RGD), transactivator of transcription
(TAT), antibodies, or small molecules [30–32]. Although
Fig. 3 Organoid forming efficiency, viability, and fluorescence signal durability. a Fluorescence signal intensity immediately after staining with
CMFDA (5–25 μM), determined by flow cytometry. b Decline in fluorescence signal intensity (15 μM CMFDA) over time. c, d PrestoBlueTM viability
assay performed consecutively c 24 h and d 48 h after staining with CMFDA (5–25 μM). Arbitrary unit (AU). No statistically significant (ns)
difference in viability was detected. e Organoid forming efficiency determined 10 days following single-cell seeding of CMFDA-stained (5–25 μM)
and unstained cells. All values were normalized to the mean of the unstained DMSO-control. A statistically significant increase was observed with
5 μM (*) of CMFDA (p = 0.03) (CMFDA median = 1.034% ICR = 0.998–1.186%, DMSO median = 1.003% ICR = 0.976–1.024%). A drastic and statistically
significant reduction of the organoid forming efficiency was observed with increasing concentrations of with CMFDA 15 μM (**) (median = 0.75%
ICR = 0.710–0.797%) and 25 μM (***) (median = 0.017% ICR = 0.013–0.024%). f Brightfield and fluorescent images of organoids at day 0 and day 3
after staining with CMFDA (15 μM), along with unstained controls, demonstrating maintained growth capacity. White scale bar, 100 μm
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targeting moieties is an option [33, 34], cell uptake of
PLGA particles is generally regulated by other modifiable
factors (e.g., particles size [35], surface charge [36–38], and
incubation time [39]). Nonetheless, primary intestinal epi-
thelial cells were unable to internalize PLGA nanoparticles
or quantum dots. This despite that the PLL-coated PLGA
particles had a comparably positive ζ-potential to what has
been used to internalize particles in other cell types [16,
21]. Additionally, the particles were only slightly larger than
100 nm, which in Caco-2 cells have been demonstrated to
be more effectively internalized than particles with a larger
diameter [40]. However, there are conflicting reports on the
Fig. 4 Cell differentiation analysis. a–d Gene expression analysis of lineage specific differentiation marker genes in unstained (DMSO) and
CMFDA-stained cells following 3 days of differentiation. Expression levels in cells cultured in standard culture medium are similarly depicted. Data
are presented as Ct-values of target genes normalized to the housekeeping gene (TBP). a CAII (enterocytes), b MUC2 (goblet cells), c LGR5
(intestinal stem cells), and d CHGA (enteroendocrine cells). A significant reduction in the expression of LGR5 (*) in CMFDA-stained cells was
detected following differentiation. No statistically significant (ns) difference was observed in the expression levels CA II or MUC2. The expression of
CHGA could be detected in a few samples only (both stained and unstained) but indicated increased expression levels following differentiation. e
Staining with hematoxylin-eosin and cytokeratin 20 (CK20) of unstained and CMFDA-labeled organoids before and after differentiation,
confirming presence of absorptive colonocytes along with secretory goblet cells in both conditions. Cell nuclei are spherical and basally located,
consistent with more differentiation phenotype. Strong reaction for CK20 after differentiation. Hence, no signs that the differentiation capacity is
affected by CMFDA. Black scale bar, 100 μm
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uptake of PLGA nanoparticles, even in Caco-2 cells, with
one study reporting limited internalization even after sev-
eral hours of incubation [39].
The targeting mechanism used in the Qtracker™ cell label-
ing kit is undisclosed and proprietary, which makes trouble-
shooting difficult, but it is possible that efficient
internalization may be achieved using alternative targeting
methods. Similarly, uptake of PLGA particles can potentially
be accomplished using other formulations or coating strat-
egies. However, the fact that we were unable to internalize
any of the nanoparticles suggests that primary intestinal epi-
thelial cells are not as readily labeled as other types of cells
(e.g., mesenchymal stem cells or cancer cell lines). Addition-
ally, particle uptake is presumably made more difficult by
the prevalent culture techniques and inherent properties of
intestinal epithelial cells. When culturing intestinal orga-
noids in Matrigel®, they spontaneously form spherical polar-
ized structures (i.e., organoids), in which the basal surface of
the cells faces the surroundings, while the apical side is ori-
ented towards the sealed off lumen. This presumably re-
duces the ability of the cells to take up exogenous
nanoparticles by means of endocytosis, as this mainly occurs
from the apical side. Internalization is made even more diffi-
cult by the fact that organoids require cell-matrix inter-
action, and that Matrigel® acts as a physical diffusion barrier.
To circumvent these obstacles, we attempted to stain both
single cells and organoid clusters while in suspension, yet
without improving cell uptake. Prolongation of the time of
incubation with nanoparticles to increase uptake is, however,
not feasible due to the high dependency of cell-basal mem-
brane interaction for intestinal organoid survival.
Intestinal epithelial cells inaptitude to internalize nano-
particles also has consequences for alternative imaging
modalities such as MRI, as it necessitates internalization
of a contrast agent (e.g., iron oxide or gadolinium), which
at least in non-phagocytic cells requires the use of nano-
particles like PLGA particles or specific coatings [41].
Our transplantation experiments suggest that it indeed
is possible to detect retained intestinal epithelial cells
using a common fluorescent dye and CLE, but the ex-
periments were qualitative rather than quantitative in
design. It still remains unclear how to best define the en-
graftment efficiency in this setting, as transplantation
commonly is performed with large numbers of organoid
fragments without knowing the exact number of cells.
Similarly, it is not clear how or when to best quantify
the number of engrafted cells, but we believe that our
tracing strategy allows for evaluation of engraftment effi-
ciency along with factors that can affect the outcome,
such as severity of ulceration and inflammation, age of
recipient, and the applied cell delivery method.
Conclusion
It is highly feasible to trace transplanted human intes-
tinal organoids using fluorescent dyes (e.g., CMFDA) in
combination with clinically approved CLE. CMFDA did
Fig. 5 Imaging in vitro and ex vivo with fluorescent microscopy and CLE. a Intestinal organoids labeled with CMFDA (15 μM) and imaged in vitro
on day 0 and day 3 with endoscope-based CLE. Standard gain settings were used. Approximately × 1000 magnification. No scale bar available.
Image diameter approximately 100–200 μm. b Rag2−/− mice were treated with dextran sodium sulfate (DSS) for 5 days. DSS was administered
for 5 days, and 4 days later (on day 9), colonic organoids derived from mT/mG mice were labeled with CMFDA and transplanted (by colonic
infusion) into the Rag2−/− mice. The recipient mice were sacrificed the subsequent day (day 10), and the colonic tissue was harvested for
analysis. c Brightfield and fluorescent images of colonic tissue mucosa from two different recipient mice (1 and 2) and three separate colonic
regions depicting retained mT/mG (red) and CMFDA (green) positive cells. White scale bar, 1 mm. d Fluorescent images of the corresponding
colonic regions (recipient mouse 1 and 2) taken with an endoscope-based CLE. No scale bar available
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not significantly affect organoid viability or growth, and
the stem cell differentiation capacity remained intact.
The approach may, although limited to short-term tra-
cing, allow confirmation of implantation at the intestinal
target site following transplantation. This, in turn,
will permit evaluation of engraftment efficiency, which is
crucial for further development of this type of novel
treatment strategy.
Additional files
Additional file 1: Table S1. Nucleotide sequences used for gene
expression analysis of differentiation markers. (DOCX 15 kb)
Additional file 2: Figure S1. Gating strategies for flow cytometry
analysis. (a) The relevant population of colonic epithelial cells was
identified based on FSC-A and SSC-A. (b) Single cells were isolated based
on the correlation between FSC-H and FSC-A. (c) eFlour™780/APC-Cy7-
negative cells were isolated, thereby excluding dead cells from the subse-
quent analysis. (d) The CMFDA-derived FITC signal intensity was subse-
quently quantified. (JPG 486 kb)
Additional file 3: Figure S2. CLE imaging of mT/mG organoids in
vitro. Murine mT/mG organoids could not be made out in vitro (left)
unless maximizing the image gain (right) and thereby drastically reducing
the image quality. (JPG 844 kb)
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